Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - 6 months ended Jun. 30, 2016 - USD ($)
Total
Common Stock [Member]
Common Stock Issuable [Member]
Additional Paid In Capital [Member]
Stockholder Note Receivable [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Series A Convertible Preferred Stock [Member]
Balance at Dec. 31, 2015 $ 6,086,766 $ 76,573 $ 0 $ 71,209,530 $ (58,824) $ 114,788 $ (65,255,301) $ 0
Balance (in shares) at Dec. 31, 2015   7,657,287 0         0
Stock -Based Compensation 237,404     237,404        
Shares Issued to Jade Therapeutics, Inc. Stockholders at Acquisition 2,909,766 $ 6,891 $ 291,536 2,611,339        
Shares Issued to Jade Therapeutics, Inc. Stockholders at Acquisition (in shares)   689,157 76,571          
Issuance of Holdback Shares from the Jade Acquisition   $ 227 $ (86,329) 86,102        
Issuance of Holdback Shares from the Jade Acquisition (in shares)   22,674 (22,674)          
Issuance of Common Stock in Offering, Net of Offering Costs 668,437 $ 4,410   664,027        
Issuance of Common Stock in Offering, Net of Offering Costs (in shares)   441,000            
Issuance of Series A Preferred Stock, Net of Offering Costs 2,776,499     2,776,471       $ 28
Issuance of Series A Preferred Stock, Net of Offering Costs (in shares)               2,777
Conversion of Series A Preferred Stock   $ 550   (549)       $ (1)
Conversion of Series A Preferred Stock (in shares)   55,000           (124)
Exercise of Common Stock Options 56,206 $ 868   55,338        
Exercise of Common Stock Options (in shares)   86,765            
Foreign Currency Translation Adjustment (1,059)         (1,059)    
Net Loss Attributable to Common Stockholders (6,265,714)           (6,265,714)  
Balance at Jun. 30, 2016 $ 6,468,305 $ 89,519 $ 205,207 $ 77,639,662 $ (58,824) $ 113,729 $ (71,521,015) $ 27
Balance (in shares) at Jun. 30, 2016   8,951,883 53,897         2,653